• Home
  • Mikhail Kosiborod
  • Home
  • Mikhail Kosiborod

Mikhail Kosiborod

Vice-President for Research, Co-Director

Cardiometabolic Center of Excellence , Saint Luke’s Mid America Heart Institute

Biography

Dr Kosiborod is an internationally recognised expert in the fields of diabetes and cardiovascular disease, cardiometabolic and cardiorenal syndromes, and quality care and outcomes. He is a cardiologist, Vice President of Research at Saint Luke's Health System, Director of Cardiometabolic Research and Co-Director of the Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence at Saint Luke's Mid America Heart Institute, and Professor of Medicine at the University of Missouri-Kansas City. Dr Kosiborod is involved in the leadership of numerous clinical trials and multi-centre registries, and is currently the principal investigator of several investigator-initiated, multi-centre trials in diabetes and cardiovascular disease.

Featured Courses

Incretin Management in Type 2 Diabetes

Mikhail Kosiborod Su Down Silvio Inzucchi et al

  • 1.00 EBAC

Published:

Learning objectives

  • Recall the components of the ‘ominous octet’ & how they contribute to T2DM development
  • Identify underlying facets of clinical inertia in T2DM care
  • Describe how early adoption of intensive glycaemic control leads to better outcomes in T2DM
  • Recall efficacy & the mode of action of various incretin-based treatments
  • Adopt an early, intensive glucose-lowering strategy in appropriate individuals 
  • Select appropriate incretin treatment & dosing regimens according to patient profiles 
  • Identify individuals likely to gain cardiovascular benefit from GLP-1RAs 
  • Select appropriate actions following adverse events from incretin-based treatments
See more